These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Chilblains in children in the setting of COVID-19 pandemic. Andina D; Noguera-Morel L; Bascuas-Arribas M; Gaitero-Tristán J; Alonso-Cadenas JA; Escalada-Pellitero S; Hernández-Martín Á; de la Torre-Espi M; Colmenero I; Torrelo A Pediatr Dermatol; 2020 May; 37(3):406-411. PubMed ID: 32386460 [TBL] [Abstract][Full Text] [Related]
23. Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent: case report and review of literature. Paparella R; Tarani L; Properzi E; Costantino F; Saburri C; Lucibello R; Richetta A; Spalice A; Leonardi L Ital J Pediatr; 2022 Jun; 48(1):93. PubMed ID: 35698236 [TBL] [Abstract][Full Text] [Related]
24. Comment on: "Acral findings during the COVID-19 outbreak: Chilblain-like lesions should be preferred to acroischemic lesions". Fernandez-Nieto D; Jimenez-Cauhe J; Suarez-Valle A; Moreno-Arrones OM; Saceda-Corralo D; Arana-Raja A; Ortega-Quijano D J Am Acad Dermatol; 2020 Sep; 83(3):e233-e234. PubMed ID: 32446824 [No Abstract] [Full Text] [Related]
25. Acral findings during the COVID-19 outbreak: Chilblain-like lesions should be preferred to acroischemic lesions. Piccolo V; Bassi A J Am Acad Dermatol; 2020 Sep; 83(3):e231. PubMed ID: 32446827 [No Abstract] [Full Text] [Related]
26. Oral cinnarizine for the treatment of COVID-19-associated chilblain-like lesions: An old drug for a new disease? Mazzatenta C; Piccolo V; Argenziano G; Bassi A Dermatol Ther; 2022 May; 35(5):e15365. PubMed ID: 35137498 [TBL] [Abstract][Full Text] [Related]
27. Recent outbreak of chilblain-like lesions is not directly related to SARS-CoV-2 infection. Rouanet J; Lang E; Beltzung F; Evrard B; Henquell C; Joulie I; D'Incan M J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):e689-e692. PubMed ID: 32589294 [No Abstract] [Full Text] [Related]
28. Frequency of relapse and persistent cutaneous symptoms after a first episode of chilblain-like lesion during the COVID-19 pandemic. Moghadam P; Frumholtz L; Jaume L; De Masson A; Jachiet M; Begon E; Sulimovic L; Petit A; Bachelez H; Bagot M; Bouaziz JD; Cassius C; J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):e566-e568. PubMed ID: 34036642 [No Abstract] [Full Text] [Related]
29. Lack of association between pandemic chilblains and SARS-CoV-2 infection. Gehlhausen JR; Little AJ; Ko CJ; Emmenegger M; Lucas C; Wong P; Klein J; Lu P; Mao T; Jaycox J; Wang E; ; Ugwu N; Muenker C; Mekael D; Klein RQ; Patrignelli R; Antaya R; McNiff J; Damsky W; Kamath K; Shon J; Ring AM; Yildirim I; Omer S; Ko AI; Aguzzi A; Iwasaki A Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35217624 [TBL] [Abstract][Full Text] [Related]
30. Chilblain and Acral Purpuric Lesions in COVID-19. Wiwanitkit V Actas Dermosifiliogr (Engl Ed); 2020 Sep; 111(7):627. PubMed ID: 32565054 [No Abstract] [Full Text] [Related]
31. COVID-19 Toes and Other Skin Lesions During the Pandemic: Emerging Entities? Vas PRJ; Georgiadis GS; Papanas N Int J Low Extrem Wounds; 2022 Dec; 21(4):658-660. PubMed ID: 33891517 [TBL] [Abstract][Full Text] [Related]
32. Not only toes and fingers: COVID vaccine-induced chilblain-like lesions of the knees. Bassi A; Mazzatenta C; Sechi A; Cutrone M; Piccolo V J Eur Acad Dermatol Venereol; 2022 Jul; 36(7):e497-e498. PubMed ID: 35188988 [No Abstract] [Full Text] [Related]
33. Chilblain acral lesions in the COVID-19 era. Are they marker of infection in asymptomatic patients? Ramondetta A; Panzone M; Dapavo P; Ortoncelli M; Giura MT; Licciardello M; Rozzo G; Siliquini N; Fierro MT; Ribero S J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):e440-e441. PubMed ID: 32421876 [No Abstract] [Full Text] [Related]
34. Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients. Piccolo V; Neri I; Filippeschi C; Oranges T; Argenziano G; Battarra VC; Berti S; Manunza F; Fortina AB; Di Lernia V; Boccaletti V; De Bernardis G; Brunetti B; Mazzatenta C; Bassi A J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):e291-e293. PubMed ID: 32330334 [No Abstract] [Full Text] [Related]
35. Chilblain-like lesions in pediatrics dermatological outpatients during the COVID-19 outbreak. Garcia-Lara G; Linares-González L; Ródenas-Herranz T; Ruiz-Villaverde R Dermatol Ther; 2020 Sep; 33(5):e13516. PubMed ID: 32378284 [TBL] [Abstract][Full Text] [Related]
36. Cutaneous manifestations in a series of 417 patients with SARS-CoV-2 infection: epidemiological and clinical correlates of chilblain like lesions. Brancaccio G; Gussetti N; Sasset L; Alaibac M; Tarantello M; Salmaso R; Trevenzoli M; Cattelan AM Pathog Glob Health; 2021; 115(7-8):483-486. PubMed ID: 33729097 [TBL] [Abstract][Full Text] [Related]
37. Are chilblain-like acral skin lesions really indicative of COVID-19? A prospective study and literature review. Docampo-Simón A; Sánchez-Pujol MJ; Juan-Carpena G; Palazón-Cabanes JC; Vergara-De Caso E; Berbegal L; Poveda-Montoyo I; Pastor-Tomás N; Mataix-Díaz J; Terencio-Alemany C; Martínez-Torres A; Miralles-Botella J; Blanes-Martínez M; González-Villanueva I; Betlloch-Mas I J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):e445-e447. PubMed ID: 32452545 [No Abstract] [Full Text] [Related]
38. Pandemic chilblains: Are they SARS-CoV-2-related or not? De Greef A; Coulie PG; Baeck M Clin Immunol; 2022 Apr; 237():108984. PubMed ID: 35338000 [TBL] [Abstract][Full Text] [Related]
39. Pediatric COVID toes and fingers. Koschitzky M; Oyola RR; Lee-Wong M; Abittan B; Silverberg N Clin Dermatol; 2021; 39(1):84-91. PubMed ID: 33972057 [TBL] [Abstract][Full Text] [Related]
40. Chilblain-like lesions in children following suspected COVID-19 infection. Colonna C; Monzani NA; Rocchi A; Gianotti R; Boggio F; Gelmetti C Pediatr Dermatol; 2020 May; 37(3):437-440. PubMed ID: 32374033 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]